Parth. Patwari, et.al., The arrestin domain-containing 3 protein regulates body mass and energy expenditure., Cell metabolism, 2011, 14

http://rdf.ncbi.nlm.nih.gov/pubmed/21982743

Parth. Patwari, et.al., The arrestin domain-containing 3 protein regulates body mass and energy expenditure., Cell metabolism, 2011, 14

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating triiodothyronine level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0005479I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• increased oxygen consumption_Arrdc3<Gt(CSE151)Byg>/Arrdc3<+>
  http://metadb.riken.jp/0005289I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3Arrdc3GtCSE151BygArrdc3
• perinatal lethality, incomplete penetrance_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0011090I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased susceptibility to hepatic steatosis_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0002310I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased circulating adrenaline level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<+>
  http://metadb.riken.jp/0005661I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3Arrdc3GtCSE151BygArrdc3
• decreased circulating glucose level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<+>
  http://metadb.riken.jp/0005560I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3Arrdc3GtCSE151BygArrdc3
• abnormal brown fat cell morphology_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0009116I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• abnormal energy homeostasis_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0005448I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased white fat cell size_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0009133I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased body length_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0001258I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• abnormal lipid homeostasis_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0002118I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased circulating insulin level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0002727I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased percent body fat/body weight_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0005459I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• abnormal adaptive thermogenesis_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0011019I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• abnormal hormone level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0003953I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased circulating glucose level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0005560I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased body weight_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0001262I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• hyperactivity_Arrdc3<Gt(CSE151)Byg>/Arrdc3<+>
  http://metadb.riken.jp/0001399I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3Arrdc3GtCSE151BygArrdc3
• increased circulating ketone body level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<+>
  http://metadb.riken.jp/0002575I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3Arrdc3GtCSE151BygArrdc3
• abnormal glucose homeostasis_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0002078I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• increased insulin sensitivity_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0002891I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased gonadal fat pad weight_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0009283I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased circulating leptin level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0005668I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• increased circulating ketone body level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0002575I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased susceptibility to age related obesity_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0003213I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased circulating triglyceride level_Arrdc3<Gt(CSE151)Byg>/Arrdc3<Gt(CSE151)Byg>
  http://metadb.riken.jp/0002644I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3GtCSE151BygArrdc3GtCSE151Byg
• decreased body weight_Arrdc3<Gt(CSE151)Byg>/Arrdc3<+>
  http://metadb.riken.jp/0001262I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3Arrdc3GtCSE151BygArrdc3
• increased basal metabolism_Arrdc3<Gt(CSE151)Byg>/Arrdc3<+>
  http://metadb.riken.jp/0008965I129P2OlaHsdC57BL6Arrdc3GtCSE151BygArrdc3Arrdc3GtCSE151BygArrdc3